Cargando…

Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes

OBJECTIVE: The risk of vessel-oriented cardiac adverse events (VOCE) in patients with diabetes mellitus (DM) undergoing intracoronary physiology-guided coronary revascularization is poorly defined. The purpose of this work is to evaluate the risk of VOCE in patients with and without DM in whom percu...

Descripción completa

Detalles Bibliográficos
Autores principales: Scarsini, Roberto, Tebaldi, Matteo, Rubino, Francesca, Sgreva, Sara, Vescovo, Giovanni, Barbierato, Marco, Vicerè, Andrea, Galante, Domenico, Mammone, Concetta, Lunardi, Mattia, Tavella, Domenico, Pesarini, Gabriele, Campo, Gianluca, Leone, Antonio Maria, Ribichini, Flavio Luciano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449663/
https://www.ncbi.nlm.nih.gov/pubmed/37338598
http://dx.doi.org/10.1007/s00392-023-02243-y
_version_ 1785095008828784640
author Scarsini, Roberto
Tebaldi, Matteo
Rubino, Francesca
Sgreva, Sara
Vescovo, Giovanni
Barbierato, Marco
Vicerè, Andrea
Galante, Domenico
Mammone, Concetta
Lunardi, Mattia
Tavella, Domenico
Pesarini, Gabriele
Campo, Gianluca
Leone, Antonio Maria
Ribichini, Flavio Luciano
author_facet Scarsini, Roberto
Tebaldi, Matteo
Rubino, Francesca
Sgreva, Sara
Vescovo, Giovanni
Barbierato, Marco
Vicerè, Andrea
Galante, Domenico
Mammone, Concetta
Lunardi, Mattia
Tavella, Domenico
Pesarini, Gabriele
Campo, Gianluca
Leone, Antonio Maria
Ribichini, Flavio Luciano
author_sort Scarsini, Roberto
collection PubMed
description OBJECTIVE: The risk of vessel-oriented cardiac adverse events (VOCE) in patients with diabetes mellitus (DM) undergoing intracoronary physiology-guided coronary revascularization is poorly defined. The purpose of this work is to evaluate the risk of VOCE in patients with and without DM in whom percutaneous coronary intervention (PCI) was performed or deferred based on pressure-wire functional assessment. METHODS: This is a retrospective analysis of a multicenter registry of patients evaluated with fractional flow reserve (FFR) and/or non-hyperaemic pressure ratio (NHPR). Primary endpoint was a composite of VOCE including cardiac death, vessel-related myocardial infarction (MI), and ischemia-driven target vessel revascularization (TVR). RESULTS: A large cohort of 2828 patients with 3353 coronary lesions was analysed to assess the risk of VOCE at long-term follow-up (23 [14–36] months). Non-insulin-dependent-DM (NIDDM) was not associated with the primary endpoint in the overall cohort (adjusted Hazard Ratio [aHR] 1.18, 95% CI 0.87–1.59, P = 0.276) or in patients with coronary lesions treated with PCI (aHR = 1.30, 95% CI 0.78–2.16, P = 0.314). Conversely, insulin-dependent diabetes mellitus (IDDM) demonstrated an increased risk of VOCE in the overall cohort (aHR 1.76, 95% CI 1.07–2.91, P = 0.027), but not in coronary lesions undergoing PCI (aHR 1.26, 95% CI 0.50–3.16, P = 0.621). Importantly, in coronary lesions deferred after functional assessment IDDM (aHR 2.77, 95% CI 1.11–6.93, P = 0.029) but not NIDDM (aHR = 0.94, 95% CI 0.61–1.44, P = 0.776) was significantly associated with the risk of VOCE. IDDM caused a significant effect modification of FFR-based risk stratification (P for interaction < 0.001). CONCLUSION: Overall, DM was not associated with an increased risk of VOCE in patients undergoing physiology-guided coronary revascularization. However, IDDM represents a phenotype at high risk of VOCE. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-10449663
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-104496632023-08-26 Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes Scarsini, Roberto Tebaldi, Matteo Rubino, Francesca Sgreva, Sara Vescovo, Giovanni Barbierato, Marco Vicerè, Andrea Galante, Domenico Mammone, Concetta Lunardi, Mattia Tavella, Domenico Pesarini, Gabriele Campo, Gianluca Leone, Antonio Maria Ribichini, Flavio Luciano Clin Res Cardiol Original Paper OBJECTIVE: The risk of vessel-oriented cardiac adverse events (VOCE) in patients with diabetes mellitus (DM) undergoing intracoronary physiology-guided coronary revascularization is poorly defined. The purpose of this work is to evaluate the risk of VOCE in patients with and without DM in whom percutaneous coronary intervention (PCI) was performed or deferred based on pressure-wire functional assessment. METHODS: This is a retrospective analysis of a multicenter registry of patients evaluated with fractional flow reserve (FFR) and/or non-hyperaemic pressure ratio (NHPR). Primary endpoint was a composite of VOCE including cardiac death, vessel-related myocardial infarction (MI), and ischemia-driven target vessel revascularization (TVR). RESULTS: A large cohort of 2828 patients with 3353 coronary lesions was analysed to assess the risk of VOCE at long-term follow-up (23 [14–36] months). Non-insulin-dependent-DM (NIDDM) was not associated with the primary endpoint in the overall cohort (adjusted Hazard Ratio [aHR] 1.18, 95% CI 0.87–1.59, P = 0.276) or in patients with coronary lesions treated with PCI (aHR = 1.30, 95% CI 0.78–2.16, P = 0.314). Conversely, insulin-dependent diabetes mellitus (IDDM) demonstrated an increased risk of VOCE in the overall cohort (aHR 1.76, 95% CI 1.07–2.91, P = 0.027), but not in coronary lesions undergoing PCI (aHR 1.26, 95% CI 0.50–3.16, P = 0.621). Importantly, in coronary lesions deferred after functional assessment IDDM (aHR 2.77, 95% CI 1.11–6.93, P = 0.029) but not NIDDM (aHR = 0.94, 95% CI 0.61–1.44, P = 0.776) was significantly associated with the risk of VOCE. IDDM caused a significant effect modification of FFR-based risk stratification (P for interaction < 0.001). CONCLUSION: Overall, DM was not associated with an increased risk of VOCE in patients undergoing physiology-guided coronary revascularization. However, IDDM represents a phenotype at high risk of VOCE. GRAPHICAL ABSTRACT: [Image: see text] Springer Berlin Heidelberg 2023-06-20 2023 /pmc/articles/PMC10449663/ /pubmed/37338598 http://dx.doi.org/10.1007/s00392-023-02243-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Scarsini, Roberto
Tebaldi, Matteo
Rubino, Francesca
Sgreva, Sara
Vescovo, Giovanni
Barbierato, Marco
Vicerè, Andrea
Galante, Domenico
Mammone, Concetta
Lunardi, Mattia
Tavella, Domenico
Pesarini, Gabriele
Campo, Gianluca
Leone, Antonio Maria
Ribichini, Flavio Luciano
Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes
title Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes
title_full Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes
title_fullStr Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes
title_full_unstemmed Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes
title_short Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes
title_sort intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449663/
https://www.ncbi.nlm.nih.gov/pubmed/37338598
http://dx.doi.org/10.1007/s00392-023-02243-y
work_keys_str_mv AT scarsiniroberto intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes
AT tebaldimatteo intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes
AT rubinofrancesca intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes
AT sgrevasara intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes
AT vescovogiovanni intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes
AT barbieratomarco intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes
AT vicereandrea intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes
AT galantedomenico intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes
AT mammoneconcetta intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes
AT lunardimattia intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes
AT tavelladomenico intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes
AT pesarinigabriele intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes
AT campogianluca intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes
AT leoneantoniomaria intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes
AT ribichiniflavioluciano intracoronaryphysiologyguidedpercutaneouscoronaryinterventioninpatientswithdiabetes